C-reactive protein levels in community-acquired pneumonia
暂无分享,去创建一个
A de Roux | E García Vázquez | J A Martínez | J Mensa | F Sánchez | M A Marcos | A Torres | J. Mensa | A. Roux | A. de Roux | F. Sánchez | M. Marcos | E. G. Vázquez | J. Martínez | A. Torres | E. García Vázquez | J. Martínez
[1] Tarja Heiskanen-Kosma, Matti Korppi. Serum C-reactive Protein Cannot Differentiate Bacterial and Viral Aetiology of Community-acquired Pneumonia in Children in Primary Healthcare Settings , 2000, Scandinavian journal of infectious diseases.
[2] A. Gautier,et al. C-reactive protein , 2005 .
[3] L. Hansson,et al. C‐reactive protein: its role in the diagnosis and follow‐up of infectious diseases , 1997 .
[4] J E Stahl,et al. Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. , 1999, Archives of internal medicine.
[5] B. Lipworth,et al. C-reactive protein. A clinical marker in community-acquired pneumonia. , 1995, Chest.
[6] J. Räsänen,et al. Quantitative C-reactive protein in relation to erythrocyte sedimentation rate, fever, and duration of antimicrobial therapy in bacteraemic diseases of childhood , 1982 .
[7] M. Fine,et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. , 1997, The New England journal of medicine.
[8] J. Macfarlane,et al. Comparative radiographic features of community acquired Legionnaires' disease, pneumococcal pneumonia, mycoplasma pneumonia, and psittacosis. , 1984, Thorax.
[9] R. Ablow,et al. Value of the C-reactive protein test in the differentiation of bacterial and viral pneumonia. , 1978, The Journal of pediatrics.
[10] I. Kushner,et al. Acute-phase proteins and other systemic responses to inflammation. , 1999, The New England journal of medicine.
[11] A. Ortqvist,et al. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia. , 1995, Scandinavian journal of infectious diseases.
[12] J. Hedlund. Community-acquired pneumonia requiring hospitalisation. Factors of importance for the short-and long term prognosis. , 1995, Scandinavian journal of infectious diseases. Supplementum.
[13] J T Macfarlane,et al. Comparative clinical and laboratory features of legionella with pneumococcal and mycoplasma pneumonias. , 1987, British journal of diseases of the chest.
[14] M. Leinonen,et al. White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. , 1997, The European respiratory journal.
[15] M. Leinonen,et al. The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. , 1987, The Journal of infection.
[16] K. Lehtomäki. Clinical diagnosis of pneumococcal, adenoviral, mycoplasmal and mixed pneumonias in young men. , 1988, The European respiratory journal.
[17] B. Lipworth,et al. C-reactive protein in simple community-acquired pneumonia. , 1995, Chest.
[18] K. Lehtomaki. Clinical diagnosis of pneumococcal, adenoviral, mycoplasmal and mixed pneumonias in young men , 1988, European Respiratory Journal.
[19] E. Vicaut,et al. Value of C-reactive protein in the detection of bacterial contamination at the time of presentation in drug-induced aspiration pneumonia. , 1997, Chest.
[20] A. Ruiz-González,et al. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown etiology? A microbiologic study of lung aspirates in consecutive patients with community-acquired pneumonia. , 1999, The American journal of medicine.
[21] E. Walsh,et al. Response of C-reactive protein and serum amyloid A to influenza A infection in older adults. , 2001, The Journal of infectious diseases.
[22] L. Hansson,et al. Sequential changes of inflammatory and nutritional markers in patients with community-acquired pneumonia. , 1997, Scandinavian journal of clinical and laboratory investigation.
[23] O. Ruuskanen,et al. Serum procalcitonin, C‐reactive protein and interleukin‐6 for distinguishing bacterial and viral pneumonia in children , 2000, The Pediatric infectious disease journal.
[24] M. Fine,et al. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. , 1999, Archives of internal medicine.
[25] R. Dessau,et al. Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo. , 2000, The Journal of antimicrobial chemotherapy.
[26] A. Torres,et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. , 1999, American journal of respiratory and critical care medicine.
[27] M. Jaakkola,et al. C-reactive Protein as a Serial Index of Severity , 1988, La Clinica pediatrica.
[28] J. Coste,et al. Procalcitonin in children admitted to hospital with community acquired pneumonia , 2001, Archives of disease in childhood.
[29] J. Morera,et al. Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias. , 1998, Chest.
[30] L. Bodin,et al. Rapid aetiological diagnosis of pneumonia based on routine laboratory features. , 1990, Scandinavian journal of infectious diseases.